From: Site of relapse of ductal adenocarcinoma of the pancreas affects survival after multimodal therapy
Recurrence/metastases | Total | Surgery | Chemotherapy | p-value 0.000 | |||
---|---|---|---|---|---|---|---|
n | % | n | % | n | % | ||
Hepatic | 43 | Â | 6 | Â | 37 | Â | Â |
Local | 28 | Â | 11 | Â | 17 | Â | Â |
Pulmonary | 17 | Â | 9 | Â | 8 | Â | Â |
Relapse Chemotherapy/procedure | Hepatic, n | Local, n | Pulmonary, n | p-value 0.900 |
---|---|---|---|---|
Gemcitabine | 27 | 12 | 5 | Â |
MD regime | 10 | 5 | 3 | Â |
FOLFIRINOX | – | – | – |  |
BSC | – | – | – |  |